Rhythm Pharmaceuticals Inc (RYTM) — Cash Flow Quality Index

Latest as of March 2021: -0.77x

Rhythm Pharmaceuticals Inc (RYTM) has a Cash Flow Quality Index of -0.77x as of March 2021. Operating cash flow of $-33.53 Million is below net income of $43.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RYTM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.77x

Operating CF / Net Income

Operating Cash Flow

$-33.53 Million

USD

Net Income

$43.75 Million

USD

Data as of

Mar 2021

Most recent filing

Annual Cash Flow Quality Index for Rhythm Pharmaceuticals Inc (None–None)

Year-by-year earnings quality comparison for Rhythm Pharmaceuticals Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.